FeaturesPrescribing

E-prescribe with EPCS gates.

In Tennessee, electronic prescribing of Schedules II–V is not a nice-to-have. It is the law. A pain clinic that treats the law as a portal on the side of the EMR will keep a paper workaround, and the workaround will be the real system.

T.C.A. § 63-1-160EPCS mandatory in Tennessee for II–V since 2021

CSMDTN PDMP: start of treatment, each new script for 90 days, then every 6 months

Draft onlyThe model never transmits a prescription

Screenshots are the synthetic demo. No real patients.

A controlled-substance draft waits on allergy review, the Tennessee CSMD check, and a clinician’s signature.

How it runs

01Draft the sigDrug, dose, and the pharmacy already on the chart.
02Clear the gatesAlerts and the PDMP check sit on the draft. Pharmacy transmission is not live.
03A clinician signsThe model does not start, stop, or send a medication.

What it is

ChartVoyant’s prescribing flow is draft → safety alerts → clinician sign. A sig is built rather than typed. The patient’s pharmacy is on the chart from check-in. Production does not transmit a prescription to a pharmacy: the prescribing adapter is synthetic, and controlled-substance transmission stays off until EPCS is credentialed. The gate that transmission would have to clear is identity-proofed EPCS, DEA-compliant two-factor, and a PDMP check against Tennessee’s Controlled Substance Monitoring Database (CSMD) via Bamboo Health’s PMP Gateway — not Ohio’s OARRS.

The visit workspace where medications mentioned in the exam become proposed orders beside the draft note. — A spoken medication is a proposal in the visit. Transmit is a later, explicit step. From the synthetic demo at demo.chartvoyant.com — no real patients.

Front-desk check-in Readiness rail including pharmacy, which is what e-prescribing needs on the chart before the room. — Pharmacy is a readiness item at the desk so the script is not waiting on a call-back at 4:40pm. From the synthetic demo at demo.chartvoyant.com — no real patients.

On the clinic floor

Each office connects its own PDMP credentials in Admin. Tennessee offices query CSMD at treatment start, before each new controlled-substance script for 90 days, then every six months. Georgia is next on the same card. Production still needs the office’s Bamboo agreement before a live query runs. DoseSpot is the Surescripts intermediary the product is built against. Production has no DoseSpot credentials, so the adapter stays synthetic: fake pharmacies, fake message ids, nothing leaves the process. Controlled-substance transmit is refused until EPCS is credentialed. That is a fail-safe, not a missing button.

What AI does, and what a clinician confirms

AI may propose a drug, a dose, and a quantity from the conversation. Drug-drug and allergy alerts are still reviewed by a person. App-level TOTP is a synthetic EPCS stand-in in demo; it is not DEA-compliant two-factor and will not be presented as such. A clinician signs. The model does not. Inbox AI does not open prescriptions.

Non-Device CDS

A suggested medication is a draft with an evidence trail. ChartVoyant does not autonomously start, stop, or change therapy. EPCS and CSMD are gates on the human, not permissions for the model.

Where this sits vs bolted-on tools

A standalone e-prescribing portal that does not know the note, the UDS panel, or the last CSMD check is how pain clinics end up with a second login and a paper printout “just in case.” ChartVoyant keeps the script in the same chart as the encounter, the PDMP row, and the claim. Surescripts transmission is a later credentialed go-live. It is not on in production, and the demo is not sending real scripts.

See the gates, not a magic send

In the synthetic demo, walk a controlled-substance proposal through confirm. Watch what is still a draft.

Try the live demo Book a walkthrough

Keep reading

Prior auth in the room, then a trackerMany pain medications are authorization problems first. The note is a draft until you attestThe same confirm posture on the document. Check-in knows what’s leftPharmacy belongs on the chart before the exam.